HC Advisors’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-1,335
Closed -$221K 69
2025
Q1
$221K Sell
1,335
-141
-10% -$22.1K 0.17% 53
2024
Q4
$213K Buy
+1,476
New +$229K 0.17% 51
2024
Q2
Sell
-1,878
Closed -$297K 65
2024
Q1
$297K Buy
1,878
+59
+3% +$9.39K 0.14% 75
2023
Q4
$285K Buy
1,819
+11
+0.6% +$1.69K 0.16% 70
2023
Q3
$282K Sell
1,808
-296
-14% -$48.8K 0.17% 65
2023
Q2
$348K Hold
2,104
0.2% 61
2023
Q1
$326K Buy
2,104
+288
+16% +$46.5K 0.2% 61
2022
Q4
$321K Buy
1,816
+326
+22% +$56.3K 0.22% 59
2022
Q3
$243K Hold
1,490
0.17% 69
2022
Q2
$264K Hold
1,490
0.19% 63
2022
Q1
$264K Sell
1,490
-34
-2% -$5.79K 0.17% 69
2021
Q4
$261K Hold
1,524
0.16% 65
2021
Q3
$246K Sell
1,524
-122
-7% -$20.8K 0.16% 63
2021
Q2
$271K Sell
1,646
-192
-10% -$31.8K 0.17% 64
2021
Q1
$302K Buy
1,838
+1
+0.1% +$162 0.2% 58
2020
Q4
$289K Buy
1,837
+3
+0.2% +$443 0.2% 64
2020
Q3
$273K Buy
1,834
+379
+26% +$56.1K 0.22% 56
2020
Q2
$205K Buy
+1,455
New +$212K 0.17% 76

Other funds holding JNJ

HC Advisors's JNJ Position: Q2 2025 in Review

HC Advisors sold out of Johnson & Johnson (JNJ) in Q2 2025, closing a stake of 1,335 shares — an estimated $221K sold.

HC Advisors first reported a position in JNJ in Q2 2020 and held it in 18 quarters. The position peaked at $348K in Q2 2023. 4,082 funds tracked by Wall St. Rank hold JNJ as of Q2 2025.

  • HC Advisors reported no remaining Johnson & Johnson position as of Q2 2025 after selling out during the quarter.
  • HC Advisors sold 1,335 Johnson & Johnson shares in Q2 2025, an estimated $221K.
  • HC Advisors first reported a position in Johnson & Johnson in Q2 2020 and held it in 18 quarters.
  • HC Advisors's Johnson & Johnson position peaked at $348K in Q2 2023.
  • 4,082 funds tracked by Wall St. Rank held Johnson & Johnson as of Q2 2025.

Based on HC Advisors's 13F filing for Q2 2025, filed 7 Aug 2025.